COVID19 STATEMENT FROM IBIOIC CEO MARK BUSTARD

I wanted to update you on IBioIC’s approach to COVID-19 during this period of incredible uncertainty.

We continue to follow the guidelines and requirements issued by the Government in response to this pandemic. The IBioIC team continue to support innovation and member requirements remotely where at all possible, therefore ensuring momentum is maintained even in the coming difficult months. Since Monday this week, our offices are now closed and all staff working from home. We will continue to interact with you via phone or online tools.

In terms of project activities in our Scale-Up Centres at University of Strathclyde and Heriot-Watt University, we have been following the requirements of these Institutions and are now shutting down the laboratories until given the all-clear to restart once again. Our Scale-Up team will continue to communicate with collaborators and customers to keep everyone informed.

IBioIC will continue to run funding competitions as appropriate but all planned events, workshops and site visits will now be cancelled until July but this is dependent on how the current situation plays out and may extend beyond this proposed timeframe. IBioIC’s support for innovation will continue and we aim to continue supporting your activities as much as possible during this challenging time.

We are also engaged with the Government about financial rescue measures that have been announced and once we have further clarity we will communicate these to our members. IBioIC has also been approached about emergency measures for security of supply of relevant materials needed as the country battles the pandemic and therefore we may be asking members about ability to provide certain services, chemicals, facilities and materials over the coming weeks and I would welcome your engagement on this.

In the meantime, I hope you and your families remain healthy and safe and if the IBioIC team can help support your business continuity, then please do not hesitate to get in touch.

Best wishes
Mark Bustard, CEO IBioIC